Devices, digital health, and the technology changing how care is delivered.
Alternative health plan designs represent much more than a passing trend. They are actively testing long-standing assumptions about how benefits should be structured, delivered, and experienced. The post Alternative Health Plan Designs Are Reshaping Employer Benefits appeared first on MedCity News .
For governments and health systems, monoclonal antibodies represent not just another drug class, but a strategic shift toward precision prevention. The post Passive Immunization: The Expanding Role of Monoclonal Antibodies in Preventive Medicine appeared first on MedCity News .
Objectives To develop phenotype algorithms for the detection of adverse events (AEs) or AE-proxies in electronic health records (EHRs), accounting for varying data availability. Design Multicentre study conducted as part of the Use Case POLAR_MI (POLypharmacy, drug interActions, Risks) of the German Medical Informatics Initiative (MII). Setting Germany. Participants Multidisciplinary teams from 10 German university sites within the MII. Interventions Not applicable. Main outcome measures Literature- and consensus-based development and operationalisation of AE algorithms using structured EHR…
We’re entering uncharted territory if bad actors can both launch zero-days and exploit unaddressed backdoors with new efficiency. This is why teams need to unify their network structure and better forecast what they’re up against. The post Preparing Healthcare Networks For The Vulnerability Flood appeared first on MedCity News .
Bionyra Pharma’s pipeline includes two drugs that target the signaling protein TL1A, alone and as part of a combination approach to treat inflammatory disorders. The startup’s launch makes it a contender in an emerging drug class that includes late-clinical assets from Merck, Roche, and partners Sanofi and Teva Pharmaceuticals. The post Inflammation Startup Bionyra Launches With $165M and Ex-Sanofi Exec at the Helm appeared first on MedCity News .
Mayo Clinic is deploying AI across its revenue cycle operations, but revenue cycle chair Todd Manion said he’s skeptical that these functions will be fully automated anytime soon. The post How Is Mayo Clinic Using AI in Its Revenue Cycle? appeared first on MedCity News .
Congressional Democrats are seeking to repeal the controversial WISeR model, but experts are unsure if their efforts will succeed. The post Is It Likely That the WISeR Model Will be Repealed? appeared first on MedCity News .
America funds the crisis. It’s time to fund the care that prevents it. The post Dying Without a Safety Net appeared first on MedCity News .
We do not need models that pretend every patient has equal or equitable access to care. We need models capable of recognizing disparities and responding to them. The post Is Bias in Clinical AI Good or Bad? It’s More Complicated Than That appeared first on MedCity News .
AI will continue changing how small molecules are discovered, but the candidates that generate the most interest in silico still have to succeed under real development conditions. The post AI Can Accelerate Discovery — Development Still Decides What Advances appeared first on MedCity News .
Through a new partnership, Marathon employer clients who don’t currently offer Lantern’s specialty care benefit can purchase it directly through Marathon. The post Lantern, Marathon Health Launch Partnership to Provide Integrated Primary and Specialty Care appeared first on MedCity News .
Kardigan was able to upsize its IPO, raising more cash for three drug candidates in mid-stage clinical development for cardiovascular conditions with no available therapies. All three programs are expected to report key data in 2027 that could pave the way for Phase 3 testing. The post Kardigan’s IPO Lands $400M for Drugs That Get to Root Causes of Heart Diseases appeared first on MedCity News .
A recent JAMA editorial from two radiologists argues that elective whole-body MRI scan companies are misleading consumers about the benefits of said scans. The radiologists argue the MRIs are more likely to trigger harmful downstream procedures than they are to save lives. Not surprisingly, the three most prominent companies offering these scans denied the charge. The post Researchers Say Whole-Body MRI Companies Are Inflating the Scans’ Medical Benefits appeared first on MedCity News .
This report describes a case of Legionnaires disease in an infant who drank formula prepared using a formula mixing device and tap water.
The international launch could benefit from Boston Scientific’s global footprint when the company closes its takeover of Penumbra.
These structures, if not set up and managed correctly from day one, can create significant accounting, tax and compliance headaches down the road. The post What Life Sciences Companies Get Wrong When Building Cross-Border R&D Structures appeared first on MedCity News .
The future of healthcare depends on enterprises moving decisively beyond the pilot trap by treating enterprise AI as a platform capable of sustaining hundreds of dynamic models. The post Beyond the Pilot Trap: How Healthcare Can Scale AI Without Losing Trust appeared first on MedCity News .
Objectives To evaluate the feasibility of using wearable inertial measurement units (IMUs; small body-worn sensors that capture linear acceleration and angular velocity) combined with machine learning (ML) to identify anterior cruciate ligament (ACL) injuries during clinical knee joint laxity assessments. Design Prospective exploratory feasibility study using a case–control design. A feed-forward neural network classifier was trained on time-normalised IMU signals recorded during Lachman and Anterior Drawer tests to distinguish ACL-injured from healthy knees. Model performance was assessed…
AI hasn’t solved all the problems plaguing healthcare’s revenue cycle — but R1’s Lee Kupferman says that it is getting closer, one gray area at a time. The post What Is AI Getting Right — and Wrong — in Healthcare’s Revenue Cycle? appeared first on MedCity News .
This cross-sectional study uses public data and expert consensus to develop and validate a reproducible census tract–level index of community digital health readiness integrating socioeconomic conditions, access to care, and digital connectivity.
Deal volumes and values are tracking above the first half of 2025, driven by Boston Scientific’s Penumbra buyout and Danaher’s Masimo acquisition.
Combined upper and lower GI endoscopy is becoming standard practice across many US healthcare settings, but the quality infrastructure for upper GI has not kept pace with the procedures now being performed on it. The post Combined GI Procedures Are Becoming Routine – AI Can Help Address the Gap in Upper GI Quality Standards appeared first on MedCity News .
The healthcare organizations getting this right are not defined by how much they’ve automated. They are defined by how deliberately they’ve protected the human touchpoints that drive trust, engagement, and outcomes. The post The Human Behind the Machine: Why Healthcare Must Resist the Rush To Automate appeared first on MedCity News .
As air transportation for organs becomes more common, both in response to tech advancements and changing federal guidelines, the industry needs tools that synchronize communication between dispersed teams and can keep pace with air transport. The post Leveraging Technology to Navigate the New Era of Continuous Organ Distribution appeared first on MedCity News .